First reported at 815 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-06-30 | 6605 |
| 2022-09-30 | 5442 |
| 2022-12-31 | 3877 |
| 2023-03-31 | 3547 |
| 2023-06-30 | 0 |
| 2024-06-30 | 1198 |
| 2024-09-30 | 18853 |
| 2024-12-31 | 0 |
| 2025-12-31 | 12763 |
| 2026-03-31 | 5352 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -32,913 (-100.0%) | 0 | $0 | 2026-07-29 | |
| Q1 2026 | Added | 32,913 | +8,000 (32.1%) | < 0.01% | $5,352 | 2026-05-11 | |
| Q4 2025 | New | 24,913 | +24,913 (0.0%) | < 0.01% | $12,763 | 2026-01-29 | |
| Q4 2024 | Reduced | 0 | -12,913 (-100.0%) | 0 | $0 | 2025-02-07 | |
| Q3 2024 | Added | 12,913 | +12,098 (1484.4%) | < 0.01% | $18,853 | 2024-11-05 | |
| Q2 2024 | New | 815 | +815 (0.0%) | < 0.01% | $1,198 | 2024-08-07 | |
| Q2 2023 | Reduced | 0 | -12,230 (-100.0%) | 0 | $0 | 2024-04-23 | |
| Q1 2023 | Unchanged | 12,230 | 0 (0.0%) | < 0.01% | $3,547 | 2024-04-23 | |
| Q4 2022 | Unchanged | 12,230 | 0 (0.0%) | < 0.01% | $3,877 | 2024-04-22 | |
| Q3 2022 | Unchanged | 12,230 | 0 (0.0%) | < 0.01% | $5,442 | 2024-04-22 | |
| Q2 2022 | New | 12,230 | +12,230 (0.0%) | < 0.01% | $6,605 | 2024-04-22 |
Who else reported the position
15 managers reported PLUS THERAPEUTICS INC for Q2 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| AIGH Capital Management LLC | New | 568,681 | +568,681 | 0.26% | $835,961 | 1 qtr |
| GEODE CAPITAL MANAGEMENT LLC | Added | 46,648 | +17,385 | < 0.01% | $68,572 | 5 qtrs |
| VANGUARD GROUP INC | Unchanged | 32,541 | 0 | < 0.01% | $47,835 | 5 qtrs |
| CITADEL ADVISORS LLC | Added | 18,283 | +7,574 | < 0.01% | $26,876 | 3 qtrs |
| BlackRock Inc | Unchanged | 6,960 | 0 | < 0.01% | $10,231 | 5 qtrs |
| Tower Research Capital LLC TRC | Added | 4,186 | +356 | < 0.01% | $6,153 | 5 qtrs |
| UBS Group AG | New | 3,199 | +3,199 | < 0.01% | $4,703 | 4 qtrs |
| Ashton Thomas Private Wealth LLC This report | New | 815 | +815 | < 0.01% | $1,198 | 1 qtr |
| ADVISOR GROUP HOLDINGS INC | Unchanged | 133 | 0 | < 0.01% | $195 | 5 qtrs |
| JPMorgan Chase & Co | Unchanged | 100 | 0 | < 0.01% | $147 | 4 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2024
- Filed
- August 07, 2024
- Filing type
- 13F-HR
- Position type
- Stock
Voting authority reported
- Sole
- 815
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.